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Introduction
Well-differentiated pulmonary neuroendocrine tumors 
(PNETs) have the ability to excrete neuropeptides, such as 
ACTH (1). In 15% of cases of Cushing’s syndrome (CS), the 
source of excess cortisol is an extrapituitary malignancy (2). 
One to five percent of all bronchial carcinoid tumors (BCTs) 
produce ectopic ACTH and can present as CS (3). 
Case presentation
A 39-year-old never smoking male presented with a 6-month 
history of worsening muscle weakness, fatigue, rest tremor, 
and increased impulsiveness (beginning of symptoms 
November 2013). He further complained about recent trunk 
weight gain, the formation of violaceous striae, and he was 
diagnosed for arterial hypertension stage 1 (May, 2014). 
Subsequently, a Dexamethasone-suppression test was 
performed and revealed a lack of natural adrenocorticotropic 
hormone (ACTH)-suppression confirming the presence of 
Cushing’s disease. In August of the same year, a MRI of the 
head displayed a reduced contrast medium uptake in the 
pituitary gland covering an area of 2 mm. A thoracic CT-scan 
(September 2014) showed a lesion in the pulmonary 
middle lobe measuring 1 cm × 1.5 cm × 1.5 cm without 
enlargement of thoracic lymph nodes (Figure 1A). Due to 
these clinical-radiologic findings, an ectopic CS caused 
by a BCT was suspected. A thoracic PET-CT scan with 
68Gallium (somatostatin analog) (October 2014) displayed a 
mildly Somatostatin-Receptor 2 (SSTR2) positive tumor in 
the middle lobe, suggesting ACTH production (Figure 1B). 
Thoracoscopic  resect ion of  the middle  lobe and 
lymphadenectomy (ten lymph nodes from station 2, 4, 7, 
10, and 12) was performed (October 2014) and histology 
revealed a typical carcinoid (<1 mitosis per 10 HPF, without 
necroses) measuring 1.9 cm with infiltration of the visceral 
pleura. Surprisingly, one out of ten resected lymph nodes 
revealed a metastasis (lymph node from the middle lobe 
bronchus, Nr. 12). The immunohistochemistry was positive 
for Synaptophysin, Keratin, also Pan-Keratin showing 
a typical patchy cytoplasmatic distribution pattern. The 
proliferation index was less than 2% resulting in a tumor 
classification of pT2a, pN1 (1/10). One day after tumor 
removal, serological values of ACTH and cortisol dropped 
to almost normal levels (Figure 2). At day of discharge, the 
patient had already weight loss, improved strength and 
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showed less impulsiveness. Specifically, the patient’s ability 
to fully work improved to 40% at three months, 60% at 
6 months and 100% at 8 months postoperatively).
At 1-year follow up, the patient had fully recovered 
from all complains, had lost 10 kg of weight, discontinued 
his antihypertensive medication and hydrocortisone as 
secondary renal insufficiency subsided and morning cortisol 
levels restored to normal levels.
Discussion 
BCTs are rare, accounting for only a maximum of 5% of 
all lung tumors. Only an estimated 1–5% of them secret 
ACTH (1). Typical BCTs rarely metastasize and they 
are defined as low-grade malignancies. Typical BCTs are 
described to display different clinical behavior among the 
subsets of ACTH-secreting BCTs. Beside, these tumors are 
associated with serious morbidity and a higher mortality risk 
when compared to their hormone-inactive counterpart (4). 
Patients with ACTH-producing typical BCTs present with 
symptoms related to CS, which can be severe and of rapid 
onset (2).
The early detection of ACTH-producing tissue remains 
challenging mainly due to a lack of validated imaging 
modalities (2). While the usage of 68Gallium-PET scan 
is recommended for those tumors (5), it failed to detect 
lymph node metastasis in our case. This could be due to 
the size threshold below 1 cm (1). The time period between 
diagnosis and eventual resection of the ACTH-secreting 
BCT can take up to 31 months (3). In case the ectopic 
ACTH-producing tumor was primarily not detected, an 
unnecessary hypophysectomy was performed in 27% of 
cases (1).
This case should alert for the necessity of a meticulous 
work up upon presentation with CS for ruling out a 
secondary ectopic ACTH-producing tumor. Although 
typical BCT rarely metastasize into regional lymph nodes, 
the fact that ACTH is produced might suggest a correlation 
with the level of aggressiveness. In these cases, surgery 
should regularly include lobectomy and lymphadenectomy.
Figure 1 Preoperative computed tomography. (A) Computed tomography of the thorax showing a tumor in the middle lobe; (B) a 
68Gallium PET-CT revealed an only weak positivity of this tumor in regard to the Somatostatin-Receptor 2 (SSTR2).
Figure 2 Laboratory values of ACTH and Cortisol show a relevant decline in levels on the first postoperative day, which correlated to the clinical 
improvement of the patient (ACTH reference rate <46 ng/L; Cortisol reference rate: 64–327 nmol/L). ACTH, adrenocorticotropic hormone.
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